BioCentury | Sep 5, 2013
Distillery Techniques

Technology: Drug platforms

...sepantronium, a survivin expression inhibitor, is in Phase II testing to treat non-Hodgkin's lymphoma (NHL). Erimos Pharmaceutical LLC's...
BioCentury | Jan 7, 2008
Company News

Chimerix management update

...Durham, N.C. Business: Infectious Hired: Neil Frazer as CMO, formerly CMO and COO of Erimos Pharmaceutical LLC WIR...
BioCentury | Jun 18, 2007
Clinical News

Terameprocol: Phase I started

...Erimos started an open-label, U.S. Phase I trial in about 24 patients. Erimos Pharmaceutical LLC , Houston, Texas...
BioCentury | Apr 23, 2007
Company News

Erimos management update

Erimos Pharmaceutical LLC , Houston, Texas Business: Cancer, Genitourinary Hired: J. Scott Mohrland as president and CEO, formerly an EVP at GMP Companies Inc.; he replaces CEO Jeff Khoo, who will become executive vice chairman WIR...
BioCentury | Apr 2, 2007
Clinical News

Terameprocol: Phase I/II started

...Erimos started an open-label, U.S. Phase I/II trial in 30 patients. Erimos Pharmaceutical LLC , Houston, Texas Product...
BioCentury | Aug 14, 2006
Company News

Erimos scientific advisory board update

Erimos Pharmaceutical LLC , Houston, Texas Business: Cancer Appointed: Jeffrey Trent, president of the Translational Genomics Research Institute; Daniel Von Hoff, EVP at the Translational Genomics Research Institute; and Steven Weitman, former CMO and SVP of...
BioCentury | Jan 30, 2006
Clinical News

EM-1421: Phase I started

...Erimos began an open-label, U.S. Phase I trial in about 30 patients. Erimos Pharmaceutical LLC , Houston, Texas...
BioCentury | Jun 27, 2005
Company News

Phase Bioscience Inc. management update

...partner with Key Partner Consulting; and Cindy Clark as president and CBO, formerly CBO of Erimos...
Items per page:
1 - 8 of 8
BioCentury | Sep 5, 2013
Distillery Techniques

Technology: Drug platforms

...sepantronium, a survivin expression inhibitor, is in Phase II testing to treat non-Hodgkin's lymphoma (NHL). Erimos Pharmaceutical LLC's...
BioCentury | Jan 7, 2008
Company News

Chimerix management update

...Durham, N.C. Business: Infectious Hired: Neil Frazer as CMO, formerly CMO and COO of Erimos Pharmaceutical LLC WIR...
BioCentury | Jun 18, 2007
Clinical News

Terameprocol: Phase I started

...Erimos started an open-label, U.S. Phase I trial in about 24 patients. Erimos Pharmaceutical LLC , Houston, Texas...
BioCentury | Apr 23, 2007
Company News

Erimos management update

Erimos Pharmaceutical LLC , Houston, Texas Business: Cancer, Genitourinary Hired: J. Scott Mohrland as president and CEO, formerly an EVP at GMP Companies Inc.; he replaces CEO Jeff Khoo, who will become executive vice chairman WIR...
BioCentury | Apr 2, 2007
Clinical News

Terameprocol: Phase I/II started

...Erimos started an open-label, U.S. Phase I/II trial in 30 patients. Erimos Pharmaceutical LLC , Houston, Texas Product...
BioCentury | Aug 14, 2006
Company News

Erimos scientific advisory board update

Erimos Pharmaceutical LLC , Houston, Texas Business: Cancer Appointed: Jeffrey Trent, president of the Translational Genomics Research Institute; Daniel Von Hoff, EVP at the Translational Genomics Research Institute; and Steven Weitman, former CMO and SVP of...
BioCentury | Jan 30, 2006
Clinical News

EM-1421: Phase I started

...Erimos began an open-label, U.S. Phase I trial in about 30 patients. Erimos Pharmaceutical LLC , Houston, Texas...
BioCentury | Jun 27, 2005
Company News

Phase Bioscience Inc. management update

...partner with Key Partner Consulting; and Cindy Clark as president and CBO, formerly CBO of Erimos...
Items per page:
1 - 8 of 8